Drugs like Ozempic may help lower 2nd stroke, heart attack risk
GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
Vaderis Receives FDA Fast Track Designation for VAD044 for the Treatment of Hereditary Hemorrhagic Telangiectasia
Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focusing on treatments for rare diseases associated with vascular malformations, today announces that the US Food and Drug ...
Medscape5d
Researchers Identify Why Some Don’t Respond to Anti-VEGF Drugs for AMD
The researchers also reported on a potential treatment, 32-134D, that in mouse studies disrupted ... and retinal ...
Finanznachrichten29m
Vaderis Therapeutics AG: Vaderis Receives FDA Fast Track Designation for VAD044 for the Treatment of Hereditary Hemorrhagic Telangiectasia
HHT, an Orphan Disease, is the second most common inherited ... Vaderis aims to be the first company to develop a medicine for the treatment of HHT and other diseases associated with vascular ...